Latest Australian Taxation Office News

BlackRock Investment Management (Australia) Limited has announced final cash distributions for 16 Australian-listed iShares ETFs, with payments scheduled for early January 2026. The announcement outlines distribution amounts, key dates, and important investor compliance reminders.

BlackRock Investment Management (Australia) Limited has announced key distribution dates for its suite of Australian iShares ETFs, including important deadlines for investors to participate in the Distribution Reinvestment Plan and comply with tax certification requirements.

Latrobe Magnesium Limited has received a $6.29 million R&D tax rebate from the ATO, using the funds to reduce debt and progress its magnesium production plants in Australia and Malaysia.

Epiminder Limited has settled a $15.77 million tax liability with the ATO related to historical R&D claims, freeing up $4.23 million from IPO proceeds for working capital.

Locate Technologies has secured court approval for its scheme of arrangement, marking a pivotal shift as its shares suspend trading on the ASX ahead of a planned delisting and NZX listing.

Charter Hall Group is set to execute a capital reallocation of 42.28 cents per security, shifting capital from its limited company shares to property trust units without cash exchanges. This move, approved by securityholders, carries important tax implications for investors.

Algorae Pharmaceuticals has secured a $384,466 cash refund from the Australian Taxation Office, reinforcing its financial position to advance AI-driven drug discovery programs.

Mantle Minerals has detailed its ongoing capital return payments through to 2027 and lodged a key tax ruling application with the ATO, signaling a smooth path for shareholder distributions.

BlackRock Investment Management (Australia) Limited has announced the final cash distributions for three Australian iShares ETFs, with payments scheduled for mid-December 2025.

Terragen Holdings has received nearly $1 million in R&D tax incentives, reinforcing its cash position and fueling ongoing development of its innovative agricultural biotech products.

The Australian Taxation Office has issued a final Class Ruling clarifying the tax treatment of TPG Telecom’s recent $3 billion capital return and special dividend, confirming no part of the capital return is taxable as a dividend.

Race Oncology has received a $2.8 million Australian R&D tax refund for FY2025, with further overseas R&D rebates expected, bolstering its clinical development of innovative cancer therapies.